Clinical Trial

Acute Stroke: Prehospital Versus In-HospitAL Initiation of Recanalization Therapy- ASPHALT

Study acronym: ASPHALT
Recruiting
View on ClinicalTrials.gov →
Summary
ASPHALT is an academic-driven open-label randomized controlled trial of Mobile Stroke Unit (MSU) deployment versus standard care in France, with blinded assessment of efficacy endpoints. 450 patients with confirmed acute ischemic stroke will be recruited over a 3-year period, with 3-month follow-up.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-12-12.
Status change: Not Yet Recruiting → Recruiting 2024-01-31
Trial Details
NCT Number NCT05649670
Lead Sponsor Centre Hospitalier St Anne
Collaborators: Assistance Publique - Hôpitaux de Paris, Ministry of Health, France
Conditions Stroke, Acute
Enrollment 450 participants
Start Date 2023-10-16
Primary Completion 2026-10-16 (estimated)
Study Completion 2027-06-16 (estimated)
Updated on ClinicalTrials.gov 2024-02-01